Literature DB >> 8683704

Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.

A A Elgamal1, N L Ectors, S Sunardhi-Widyaputra, H P Van Poppel, B J Van Damme, L V Baert.   

Abstract

PURPOSE: We explored the immunohistochemical expression of prostate specific antigen (PSA) in pancreas and salivary glands.
MATERIALS AND METHODS: We investigated 62 specimens from male and female subjects, representing normal cases and several pathological conditions of pancreas and salivary glands. Two commercially available monoclonal antisera for PSA and 1 for prostatic acid phosphatase were used.
RESULTS: A consistently positive reaction for PSA and prostatic acid phosphatase, independent of patient sex, was noted in ductal cells of normal pancreas and normal salivary glands, as well as pleomorphic adenoma, adenocarcinoma and all oncocytic epithelial cells of Warthin's tumor. Reaction was absent in normal stromal and acinar cells, and squamous carcinoma.
CONCLUSIONS: PSA is detectable in normal and cancer tissues far from the prostate. Therefore, we may not entirely rely on specificity of PSA alone to diagnose metastatic prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683704     DOI: 10.1097/00005392-199608000-00040

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Low detectable prostate specific antigen after radical prostatectomy--treat or watch?

Authors:  Dmitry Koulikov; Maura C Mohler; Diana C Mehedint; Kristopher Attwood; Gregory E Wilding; James L Mohler
Journal:  J Urol       Date:  2014-05-21       Impact factor: 7.450

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

3.  Prostatic acid phosphatase expression in human tissues.

Authors:  Thomas J Graddis; Catherine J McMahan; Jennifer Tamman; Keith J Page; James B Trager
Journal:  Int J Clin Exp Pathol       Date:  2011-03-22

4.  Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.

Authors:  Angela Queisser; Susanne A Hagedorn; Martin Braun; Wenzel Vogel; Stefan Duensing; Sven Perner
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 5.  Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Authors:  Zacharoula Panteleakou; Peter Lembessis; Antigone Sourla; Nikolaos Pissimissis; Aristides Polyzos; Charalambos Deliveliotis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

Review 6.  Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.

Authors:  T J Wallace; T Torre; M Grob; J Yu; I Avital; Bldm Brücher; A Stojadinovic; Y G Man
Journal:  J Cancer       Date:  2014-01-01       Impact factor: 4.207

7.  Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate.

Authors:  M Onozawa; K Fukuda; M Watanabe; M Ohtani; H Akaza; T Sugimura; K Wakabayashi
Journal:  Jpn J Cancer Res       Date:  2001-08

8.  Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.

Authors:  Ming Yin; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2007-10-27       Impact factor: 2.644

Review 9.  Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.

Authors:  Tamara Sequeiros; Marta García; Melania Montes; Mireia Oliván; Marina Rigau; Eva Colás; Inés de Torres; Juan Morote; Jaume Reventós; Andreas Doll
Journal:  Biomed Res Int       Date:  2013-11-25       Impact factor: 3.411

Review 10.  Reassessing target antigens for adoptive T-cell therapy.

Authors:  Christian S Hinrichs; Nicholas P Restifo
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.